Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
Clinical trial NCT05389267 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05389267
- Sponsor
- Laboratoires Thea
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2024-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.